Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • adam_ie
    Junior Member
    • Aug 2013
    • 3

    Enriching bacterial RNA from infection samples

    Hi all,

    I am working with RNA samples from in vitro infections of cells with bacteria. I would like to sequence the bacterial component of these samples. From a previous sequencing effort, I know that the vast majority (>99%) of the RNA comes from the host (eukaryotic) cells.

    I previously attempted to deplete the eukaryotic and prokaryotic ribosomal RNA, as well as Poly-A transcripts, to leave only bacterial non-ribosomal RNA, but this did not prove sufficient and the vast majority of the RNA is still eukaryotic. Instead, I'm now considering the opposite strategy of enriching the bacterial RNA prior to sequencing.

    From the data I have, I know that the amount of bacterial RNA that I actually want (i.e. non-ribosomal bacterial RNA) is in the range of ~1ng upwards per sample. One option that I am exploring to selectively enrich this RNA is the use of the SureSelect RNA Capture kit from Agilent (or a similar kit) using probes covering the whole genome of the bacterium.

    I'm wondering if anyone has experience with a similar approach, or with enriching bacterial RNA from mixed samples generally? Will the SureSelect kit, or a similar kit, be able to handle an input as low as 1ng if it accounts for less than 1% of the sample?

    Any thoughts or comments appreciated! Thanks
    Last edited by adam_ie; 04-09-2015, 05:49 AM.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    I previously attempted to deplete the eukaryotic and prokaryotic ribosomal RNA, as well as Poly-A transcripts, to leave only bacterial non-ribosomal RNA, but this did not prove sufficient and the vast majority of the RNA is still eukaryotic. Instead, I'm now considering the opposite strategy of enriching the bacterial RNA prior to sequencing.
    I wonder if you have used this commercial product which follows a similar approach: http://www.lifetechnologies.com/au/e...tic-hosts.html

    From the data I have, I know that the amount of bacterial RNA that I actually want (i.e. non-ribosomal bacterial RNA) is in the range of ~1ng upwards per sample. One option that I am exploring to selectively enrich this RNA is the use of the SureSelect RNA Capture kit from Agilent (or a similar kit) using probes covering the whole genome of the bacterium.
    In theory this should work as long as you have enough RNA (mix of host and microbe) equivalent to mRNA input requirement of the kit.

    Comment

    • adam_ie
      Junior Member
      • Aug 2013
      • 3

      #3
      Originally posted by nucacidhunter View Post
      I wonder if you have used this commercial product which follows a similar approach: http://www.lifetechnologies.com/au/e...tic-hosts.html
      Yep, that's exactly the method I tried, without success. The proportion of eurkaryotic RNA seems to just be too high, even though it was considerably depleted with the above kit.

      I'm now thinking that enrichment of the bacterial RNA is the only way to go in this case.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM
      • GATTACAT
        Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by GATTACAT
        Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
        07-01-2026, 11:43 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Working...